News

Sabo Announces Agreement with BASF

Borealis Sells Melamine Process Technology to Urea Casale SA

Archroma Begins New Era in Delivering Color And Specialty Chemicals

Roche Breast Cancer Drug Gets U.S. Pre-Surgery Approval

Ineos Unveils Grangemouth 'Survival Plan' with Job Cuts

Astrazeneca CEO Gets Two Cheers after First Year in Job

Indium for LCDs Surges on Chinese Investor Demand

Clariant Acquires Organic Pigment Business of Jiangsu Multicolor and Invests in New Plant in China

Oxea Expands Alcohol Portfolio to Include 3-Methylbutanol

Chemical manufacturer Oxea announced that it is expanding its portfolio of higher alcohols with 3-methylbutanol (isoamyl alcohol), a versatile intermediate product for the chemical industry.

Olivier Brandicourt Appointed as New CEO of Bayer Healthcare

Akzonobel Investing €50m in Western China, to Meet Growing Demand

AkzoNobel: Phasing of Restructuring Charges between Q3 and Q4 2013

Oxea’s Ruhrchemie Plant Honored as “Historical Landmark of Chemistry”

On their anniversary "75 years of oxo synthesis", Oxea and the Association of German Chemists (GDCh) recognized the pioneering work of Dr. Otto Roelen in the field of hydroformylation (oxo synthesis).

Beraca and L’Oréal Invest in The Brazilian Biodiversity with Murumuru Butter

Infinity Pharma's Cancer Drug Fails Mid-Stage Trial Goals

Gazprom Plans LNG Import Terminal in Baltic Enclave

Merck KGaA to Continue Testing Cancer Vaccine

Oxea Celebrates 75 Years of Oxo Synthesis

On September 20, 1938, the German chemist, Dr. Otto Roelen, then the research director at Ruhrchemie in Oberhausen (now Oxea), filed a patent application for the oxo synthesis.

Indian Pharma Industry Trends

Total to Start "Soft Landing" from Years of Record Capital Spending

Syngenta May Be Template as Novartis Reviews Non-Core Assets

BASF Announces Cash Offer to Acquire Specialized Enzyme Biotechnology Company Verenium

Clariant's Newest ColorWorks Opens Near Chicago

Aesica Unveils New Manufacturing Facility Investing £30 Million

Sanofi in $40 Million Settlement over Obesity Drug Linked to Suicidal Thoughts

Roche Decides Against Selling Diabetes Device Unit

Biesterfeld Spezialchemie to Represent DIC Performance Resins

AstraZeneca Looks for New Heart Drug Approval by Next May

General Electric Names New Head of Oil and Gas Unit

Total CEO Considers Increasing Its Asset Sales Target

Ehrfeld Mikrotechnik BTS and Alfa Laval Cooperate in Millireactor Technology

Lanxess Seeks to Increase Competitiveness

SK Capital Announces New Archroma Leadership Team

Biesterfeld Expands Cooperation with Salicylates And Chemicals

Biesterfeld Expands Cooperation with Tereos Group